ACELYRIN(SLRN) - 2024 Q2 - Earnings Call Presentation

Accelerating Medicines to Transform Patients' Lives Q2 2024 Financial Results August 13, 2024 Forward Looking Statements & Disclaimer This presentation contains statements that are not of historical facts, considered forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include, but are not limited to, statements about our expectations regarding the potential benef ...